THE NEWS: A pharmaceutical executive has been arrested for allegedly using nonpublic information about companies that were potential acquisitions for his employer, Bristol-Myers Squibb. Investigators say he made affiliated stock trades that netted him $310,000.
THE PERP: Robert Ramnarine, 45, was first director and later executive director of the arm of the company responsible for pension and savings investments. He was tasked with completing due diligence on companies Bristol-Myers targeted for acquisitions and was given information about the firms' pension plans.
THE POTENTIAL PUNISHMENT: If convicted, Ramnarine faces up to 20 years in prison and fines of $5 million.